Related Experiment Videos
Hypoxia-Induced increase in FDG uptake in MCF7 cells
P Burgman1, J A Odonoghue, J L Humm
1Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Summary
Hypoxia increases fluorodeoxyglucose (FDG) uptake in breast cancer cells by enhancing glucose transporter activity, not hexokinase levels. This finding aids in understanding FDG-PET imaging for tumor hypoxia detection.
Area of Science:
- Biochemistry
- Oncology
- Medical Imaging
Background:
- Tumor hypoxia negatively impacts cancer treatment outcomes, necessitating noninvasive detection methods.
- Increased fluorodeoxyglucose (FDG) uptake in hypoxic regions suggests PET imaging potential.
- This study investigates the mechanism of hypoxia-induced FDG uptake in MCF7 breast cancer cells.
Purpose of the Study:
- To elucidate the cellular mechanisms behind increased FDG uptake under hypoxic conditions in MCF7 cells.
- To determine the roles of glucose transporter and hexokinase activity in hypoxia-induced FDG uptake.
Main Methods:
- MCF7 cells were incubated under hypoxic and normoxic conditions with and without redox agents.
- 3H-FDG uptake was measured, alongside glucose transporter and hexokinase activity assays.
- Cellular protein levels of glucose transporters and hexokinase were assessed.
Main Results:
- Hypoxia significantly increased 3H-FDG uptake (over twofold) without altering glucose transporter or hexokinase protein levels.
- Reducing agent DTT increased FDG uptake and glucose transporter activity, suggesting a shared mechanism with hypoxia.
- Oxidizing agent pCMBS counteracted hypoxia's effect on FDG uptake.
Conclusions:
- Hypoxia-induced FDG uptake in MCF7 cells is partly due to increased glucose transporter activity via thiol group modification.
- Hexokinase activity modulation is unlikely to be involved in this hypoxia-induced FDG uptake.
- Findings contribute to understanding FDG-PET as a tool for detecting tumor hypoxia.